Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 5/20 | 0.36 |
| ▸ | HTR2C | P28335 | 5/20 | 0.36 |
| ▸ | HTR2B | P41595 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.30 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tert-Butyl Formate SCHEMBL27552576 | 0.82 | TDP1 (0.37) | HTR2AHTR2CHTR2BTDP1 | |
| Tert-Butyl Formate SCHEMBL27763665 | 0.76 | AKR1B1 (0.40) | TDP1 | |
| Tert-Butyl Formate SCHEMBL28024456 | 0.72 | TDP1 (0.45) | HTR2ATDP1 | |
| Tert-Butyl Formate SCHEMBL28114797 | 0.72 | DRD2 (0.43) | — | |
| Tert-Butyl Formate SCHEMBL27512007 | 0.72 | ALDH1A1 (0.47) | TDP1 | |
| SCHEMBL16321867 | 0.71 | ESR2 (0.44) | — | |
| Tert-Butyl Formate SCHEMBL28087021 | 0.71 | PROKR1 (0.44) | — | |
| SCHEMBL15536669 | 0.71 | PROKR1 (0.32) | DYRK1A | |
| Tert-Butyl Formate SCHEMBL28873271 | 0.69 | TDP1 (0.48) | TDP1 | |
| Tert-Butyl Formate SCHEMBL17956858 | 0.66 | TDP1 (0.52) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104520292-B | Sulphonylpiperidine derivant and they are for treating the purposes of disease of front dynein mediation | 武田药品工业株式会社 | 2016-09-14 | — | — | CN | disclosed |
| CN-105324372-A | 1-sulfonylpiperidine derivatives as prokineticin receptor modulators | TAKEDA PHARMACEUTICAL | 2016-02-10 | — | — | CN | disclosed |